Dr. Atil Kargi, MD (he/him) is an Endocrinologist in Miami, FL with over 15 years of experience. What is your opinion of Dr. Atil Kargi, MD? Rate this provider below so other people can make informed decision.
Over 15 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Atil Kargi, MD has received over $22,992 which includes payments from the following companies:
$6,633.75 from Strongbridge US INC.
$5,937.29 from Pfizer Inc.
$3,050.24 from LILLY USA, LLC
$3,025.00 from RECORDATI_RARE_DISEASES_INC.
$2,777.12 from Novo Nordisk Inc
$340.81 from Corcept Therapeutics
$226.56 from Shire North American Group Inc
$173.54 from Ipsen Biopharmaceuticals, Inc
$130.30 from sanofi-aventis U.S. LLC
$112.40 from E.R. Squibb & Sons, L.L.C.
$100.00 from GENZYME CORPORATION
$95.24 from Endo Pharmaceuticals Inc.
$72.60 from AstraZeneca Pharmaceuticals LP
$69.21 from Janssen Pharmaceuticals, Inc
$65.74 from Regeneron Healthcare Solutions, Inc.
$57.55 from Novartis Pharmaceuticals Corporation
$20.06 from Amgen Inc.
$17.16 from Auxilium Pharmaceuticals, Inc.
$16.55 from Tandem Diabetes Care, Inc.
$16.14 from Eisai Inc.
Payments received by Dr. Atil Kargi, MD were from the following categories:
$6,024.77 Food and Beverage
$3,000.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!